weight loss drugs
Gold, silver, and copper hit record highs; strong GDP data weighs on US stock futures | Tonight's Highlights
1. Metals surge continues, with spot gold, silver, and LME copper all hitting record highs; 2. US Q3 GDP data exceeds e...
Stock
2026-01-12
The price of the weight-loss miracle drug has dropped from $1,350 per month to $350. The GLP-1 market will shift from a duopoly in the United States to multi-dimensional competition.
Recently, Eli Lilly and Nord Agreement reached with the US government on GLP-1 weight loss drug Significant price reduc...
Stock
2026-01-12
A crucial bidding war for weight-loss drugs: Pfizer may raise its bid to compete with Novo Nordisk for Metsera.
The bidding war surrounding obesity biotechnology company Metsera is intensifying, with reports indicating that Pfizer....
Stock
2026-01-12
New CEO throws cold water on things right after taking office? Novo Nordisk lowers growth forecast for weight loss drugs.
①Novo Nordisk The third-quarter financial report showed that its quarterly sales increased by 15% year-on-year, of whic...
Stock
2026-01-12
